|
Current Researchers: R.
N. Beachy
Previous Researchers: M. Bendahmane, J. Fitchen, G. Lettieri, Yao,
M. Koo, S. Asurmendi
For more than 75 years, agriculturists have
known that inoculating crop plants with a mild strain of a virus can prevent
infection by a severe strain. The mechanism that accounted for this protective
effect was unknown, but researchers reasoned that incorporation of viral genes
into plants may be able to produce the same effect.
In the mid-1980s, Dr. Roger Beachy and his
co-workers conducted pioneering experiments in which they inserted into tobacco
plants the gene that codes for the coat protein (CP) of the tobacco mosaic virus
(TMV). They found that the transgenic plants carrying the CP gene did not show
symptoms of infection after exposure to TMV; the plants were effectively virus
resistant. This type of resistance is referred to as coat protein-mediated
resistance (CP-MR). Researchers
working in Dr. Beachy's laboratory have continued the work of deciphering the
mechanism responsible for virus resistance with the goal of enhancing the
effectiveness of CP-MR.
Studies of the mechanisms of coat
protein-mediated resistance:
- The presence of TMV CP reduces the
disassembly of infecting virus particles:
When TMV particles are introduced into a plant cell, the outer layer consisting
of coat protein molecules, begins to disassemble. This exposes
the viral RNA genome which can then serves as mRNA for the viral
replicase, the enzyme responsible for replicating the viral genome.
In a plant cell that contains CP produced by the transgene,
virus disassembly is inhibited and fewer viral particles are
replicated. The greater the amount of CP, the higher the degree
of resistance. Furthermore, CP-MR is more effective against tobamoviruses
that are closely related to TMV than against distantly related
tobamoviruses. Work continues on finding how CP prevents disassembly.
- Analyses of selected CP
mutants are providing information about the mechanisms of CP-mediated resistance.
Certain CP mutants confer higher levels of CP-mediated resistance than does wild type CP. Mutations in CP that cause increased interactions between CP molecules led to greater resistance.
Like wild type CP, certain mutants reduce the number of sites of infection in transgenic plants, while other mutants had little effect on infection, but limited replication and/or disease.
Ongoing studies include structural analyses of selected CP mutants to clarify the
interactions within and between CP molecules that are responsible for increasing the levels of CP-MR.
|